Enter inventor name

Stewart K Richardson

USPTO Granted Patents = 26 (Patent Applications = 1)

Average Co-Inventor Count = 5.5

ph-index = 11

Forward Citations = 295(Granted Patents)

Location History:

Ashford, CT (US) (1998 - 2007)
Tolland, CT (US) (2001 - 2012)

Company Filing History:

University of Connecticut

patents

4. 1 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12268700 - 3-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses thereof (2025-04-08),

2. 8304409 - Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use (2012-11-06),

3. 8222277 - Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use (2012-07-17),

4. 8088762 - Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use (2012-01-03),

5. 7883714 - Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use (2011-02-08),

6. 7754772 - Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use (2010-07-13),

7. 7687500 - Substituted oxetanes, method of making, and method of use thereof (2010-03-30),

8. 7442802 - Cyclooxygenase-2 selective inhibitors, compositions and methods of use (2008-10-28),

9. 7351827 - Substituted oxetanes, method of making, and method of use thereof (2008-04-01),

10. 7345037 - Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders (2008-03-18),

11. 7332505 - Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use (2008-02-19),

12. 7244753 - Cyclooxygenase-2 selective inhibitors, compositions and methods of use (2007-07-17),

13. 7238814 - Compositions of S-nitrosothiols and methods of use (2007-07-03),

14. 7211598 - Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use (2007-05-01),

15. 7163958 - Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use (2007-01-16),

Title: Stewart K Richardson: Innovator in Nitrosated Nonsteroidal Anti-Inflammatory Compounds

Introduction

Stewart K Richardson, an accomplished inventor based in Tolland, CT, has made significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 25 patents, Richardson has focused his research on developing innovative solutions to treat various medical conditions, particularly through the use of nitrosated nonsteroidal anti-inflammatory drugs (NSAIDs).

Latest Patents

Richardson's latest patents revolve around nitrosated nonsteroidal anti-inflammatory compounds, compositions, and methods of use. His inventions describe novel nitrosated NSAIDs and pharmaceutically acceptable salts designed to enhance therapeutic efficacy. These compositions may include compounds that donate, transfer, or release nitric oxide, which is crucial for promoting a range of therapeutic outcomes. The inventions provide methods for treating inflammation, pain, and fever, as well as gastrointestinal disorders, facilitating wound healing, and preventing toxicities related to NSAID use. Additionally, they propose novel kits combining nitrosated NSAIDs with nitric oxide donors, aimed at treating various inflammatory diseases and ophthalmic disorders.

Career Highlights

Stewart K Richardson has had a noteworthy career, having worked with prominent firms such as Nitromed, Inc. and Nicox S.A. His expertise in pharmaceutical research has enabled him to lead innovative projects that focus on enhancing drug safety and efficacy. Throughout his career, Richardson has been recognized for his groundbreaking work in drug formulation and development.

Collaborations

During his career, Richardson collaborated with notable colleagues such as David S Garvey and L Gordon Letts. These partnerships have fostered an environment of creativity and innovation, allowing for the exploration of new therapeutic approaches in the pharmaceutical arena.

Conclusion

Stewart K Richardson exemplifies the spirit of innovation in the pharmaceutical industry. His extensive research and numerous patents highlight a commitment to improving healthcare outcomes through novel medicinal compounds. As he continues to advance his work, the impact of his inventions in treating inflammatory and related disorders is expected to be profound.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com